|Videos|January 12, 2023
MF Progression to Acute Myeloid Leukemia and Subsequent Treatment
Author(s)Ruben Mesa, M.D., Rami S. Komrokji, M.D.
Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.
Advertisement
Episodes in this series
Advertisement
Related to this article
Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable in his own skin at 60.
Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung cancer in the phase 1b FURTHER trial.
Debbie Legault, whose daughter was diagnosed with breast cancer at 27, urges shoppers to skip pink ribbon products and donate directly to support organizations.
A study of 52,236 patients with cancer found that episodes of unintended weight loss affected 46.63% of patients and were tied to shorter overall survival.
Diagnosed with leukemia at 8 years old, Harper feared that losing her hair would change who she was. She reflects on body image, confidence and finding a sense of herself during cancer treatment.
A psycho-oncologist answers 5 common questions about cancer-related anxiety, depression, fear of recurrence and emotional well-being.
U.S. counties where more residents had medical debt in collections had higher rates of late-stage lung, head and neck, colorectal and several other cancers, according to a study of 2,958 counties published in October 2026 in JAMA Network Open.
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Advertisement
Advertisement
Trending on CURE
1
Stage 4 Breast Cancer: How a Second Opinion Saved Her Life
2
Psycho-Oncologist Answers 5 Common Questions About the Emotional Impact of Cancer
3
How a Cancer Survivor Learned to Stop Hiding His Surgical Scars
4
FDA Flags Possible Colitis Risk With CDK4/6 Breast Cancer Drugs
5